about
Guidelines for the use and interpretation of assays for monitoring autophagyGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotesDAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagyEpigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicityNeuregulin promotes incomplete autophagy of prostate cancer cells that is independent of mTOR pathway inhibitionDifferential interactions between Beclin 1 and Bcl-2 family membersThe involvement of ErbB4 with schizophrenia: association and expression studiesIdentification of nucleolin as new ErbB receptors- interacting proteinEpizootic hemorrhagic disease virus induces and benefits from cell stress, autophagy, and apoptosis.Structure-function analysis of nucleolin and ErbB receptors interactions.ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell deathChloroquine synergizes with FTS to enhance cell growth inhibition and cell deathBrain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes.Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brainContinuous treatment with FTS confers resistance to apoptosis and affects autophagy.Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer.Ras and autophagy in cancer development and therapy.Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury.Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.Enhancing FTS (Salirasib) efficiency via combinatorial treatment.Ras inhibition enhances autophagy, which partially protects cells from death.EGF receptor family: twisting targets for improved cancer therapies.Beclin 1 self-association is independent of autophagy induction by amino acid deprivation and rapamycin treatment.Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations.Neuregulin rescues PC12-ErbB4 cells from cell death induced by H(2)O(2). Regulation of reactive oxygen species levels by phosphatidylinositol 3-kinase.DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia.The Interplay Between Apolipoprotein E4 and the Autophagic-Endocytic-Lysosomal Axis.Rapamycin is a neuroprotective treatment for traumatic brain injury.Neurodegeneration induces upregulation of Beclin 1.Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation.Closed head injury induces upregulation of Beclin 1 at the cortical site of injury.Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer.Blood Glutamate Scavenger as a novel neuroprotective treatment in spinal cord injury.Rapamycin increases neuronal survival, reduces inflammation and astrocyte proliferation after spinal cord injury.ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network.Decreased anti-regenerative effects after spinal cord injury in spry4−/− miceCloned rat M3 muscarinic receptors mediate phosphoinositide hydrolysis but not adenylate cyclase inhibitionClosed head injury induces up-regulation of ErbB-4 receptor at the site of injury
P50
Q21996341-1F98BEAC-59DE-4340-8695-E6488E251F0CQ22676705-D6A46969-56C9-46E0-AD0C-3F852B59EC6FQ23757358-FDFA1359-8281-4578-A377-530997DCFB7CQ24323360-7EFF4123-A153-4CC5-9C94-077431DD7C5BQ24324102-CFEB6A43-57F8-4F88-B755-C97EE488A918Q27303158-6B45B6A3-9018-44DC-A8F5-1ADC7E8EBB9FQ28237258-A18C32F8-4FDF-472D-A45A-BAA6DD977877Q28290653-D8C3934A-09D8-4D78-8545-7D1D3BC82D23Q28578177-32EB5D0C-D2EB-45F7-AD82-51315336CD14Q30557606-6768BC78-1244-4663-8D98-3118A74A4EBDQ33478425-C109F7E9-B32C-4469-98F2-F0B426F1BFE6Q33781099-A03E8D38-6E42-43F7-B35C-F91B77A7F5A8Q35005500-84811033-791B-421C-A8FC-0A39DC3D5D5BQ35076007-2201F233-176B-4084-B37A-6C54BF5BDACAQ35784936-3449A3EE-4D91-493D-87E7-F84AE2652BD9Q35895254-0DFCC478-EE91-46D7-A812-7EB01822DD47Q36267411-45E870AE-2B10-48B9-B8E7-D3976D5007B9Q37662229-468A5351-B234-4F1A-8C52-8714EE6C8598Q38192416-E24229F7-662A-4FA5-961B-678B76411B20Q38291753-C9DDA5FD-5F6B-454C-8CC9-57E4AE0F4F03Q38303924-32C25E7D-86DB-4F5A-84DC-544B4864BD8FQ38367291-B412BD04-3B8F-4D49-A591-BFDE3EB11EABQ39201276-CFBCF6EB-125D-4376-8B24-1DBDD2E6A6BFQ39228711-F146D703-911B-478F-AADD-4F1F89A671CAQ39690488-F466148D-5EBE-4CFD-94CC-6A085C89F244Q41175866-0A271ACF-F464-4261-971D-0FA423C8F16FQ43759018-85EAB5D6-2007-46E7-AB70-A5273D9E5878Q47786526-B73069F5-7E5B-4CFC-B1A2-943995E78C95Q48201452-0BA3BC4F-33E9-4260-AABD-6617281D4821Q48290046-03134394-BECB-417B-80FD-7A7974325427Q48460648-B9D2CC33-041E-4867-9766-B9BBF84A6B90Q48570258-FA82FDC8-0DE9-418D-8A5E-516FCE7D844EQ48820012-490C168B-D18B-42BC-BF16-A4078578DAB6Q49909762-DAB06F9B-FDE3-400C-A010-466F41EEE4C6Q52678855-D2502EC6-CCC5-4001-8570-5847DC5F6BDAQ53518870-43F2967A-F1E9-4ED0-8241-0D147F89E120Q55500136-7774310C-80FF-415C-AB1B-91648BD37FE7Q60721721-3BD5FC4A-444F-4E43-938B-E24FE5F96558Q69840770-411B0B1C-CB29-4BB6-9F35-0BA9654A7A43Q73204072-22E9E297-313D-4D18-B971-B547BB80150D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ronit Pinkas-Kramarski
@ast
Ronit Pinkas-Kramarski
@en
Ronit Pinkas-Kramarski
@es
Ronit Pinkas-Kramarski
@nl
Ronit Pinkas-Kramarski
@sl
type
label
Ronit Pinkas-Kramarski
@ast
Ronit Pinkas-Kramarski
@en
Ronit Pinkas-Kramarski
@es
Ronit Pinkas-Kramarski
@nl
Ronit Pinkas-Kramarski
@sl
prefLabel
Ronit Pinkas-Kramarski
@ast
Ronit Pinkas-Kramarski
@en
Ronit Pinkas-Kramarski
@es
Ronit Pinkas-Kramarski
@nl
Ronit Pinkas-Kramarski
@sl
P106
P31
P496
0000-0002-1000-369X